Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × proxalutamide × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castrate Resistant Prostate Cancer (mCRPC) 2 Severe Acute Respiratory Syndrome 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Neoadjuvant Therapy \High Risk Prostate Cancer 1 COVID-19 1 Alopecia 1

Interventions

Standard of Care 2 Pandemic Preparedness 2 tocilizumab 1 proxalutamide 1 Practice Guidelines as Topic 1 Immunoglobulin G 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Applied Biology, Inc.

Phase NA Completed

268 enrolled 8 charts

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡